Administration of Medicines, Food and C Level Contact List Medical Technology (ANMAT). Today the Argentine pharmaceutical market is an asymmetric and cartelized enclave, with a strong presence of local capital: 20 laboratories (of which 13 are national) that C Level Contact List account for 67% of the total turnover but participate modestly in economic growth (1% of GDP, 6 % of the industrial sector), in part due to its peak character (skilled employment, capital intensive), C Level Contact List which isolates the sector from its underdeveloped environment; in part, due to its deficit dependence on imported inputs.
One of the legal loopholes that the laboratories C Level Contact List most harshly defended was their refusal to pay patents for the use of foreign formulas, despite the claims of laboratories and even governments of other countries. It was only in 1995 that a C Level Contact List patent law was approved and even so, the national laboratories were able to extend it for five years, maintain control of the internal market and force international laboratories to import directly or C Level Contact List dedicate themselves to selling patents. Sigman landed on this wild market after returning from exile, during the neoliberal reforms of the 1990s. Associated with the Sielecki family (from Phoenix laboratories) and the rest of the Gold family (from Sintyal), he acquired
Elea, a company specialized in in highly complex C Level Contact List hormonal products, which it has since supplied to companies such as Merck, Pfizer and AstraZeneca. The 1994 FMD campaign was Sigman's next opportunity to form a consortium. Foot-and-mouth disease had devastated cattle in the region since the beginning of the 20th century, with major C Level Contact List local epidemics in 1942 and 1966. At the end of the 1970s, it was decided to replace traditional vaccines with other oil-based ones, which were mandatory as of 1994. To manufacture the new vaccine, the C Level Contact List laboratories had to face a costly reconversion. Chemotécnica Sintyal merged with Biogenesis and gave birth to Biogenesis Sintyal, which soon exported the vaccine throughout the region. In 1998 Roberto Gold died. Hugo and Silvia's company had come of age.